White Paper

2024 Global Biopharma Sustainability Review

Source: Cytiva
GettyImages-1903972230 Sustainability Concept, Green Forest With Globe Earth

What steps is the biopharma industry taking to enhance sustainability? What challenges does biopharma encounter? And how can the entire industry draw lessons from the companies that are setting the standard?

Cytiva collaborated with FT Longitude to conduct the research necessary to address these important questions. The findings reveal that sustainability has become a top priority in the industry, biopharma leaders understand the need for decarbonization, and industry leaders report significant progress in reducing water consumption, optimizing electricity use, and increasing reliance on recyclable materials.

This report draws on data from 800 pharma and biopharma professionals at the director level and above. These professionals span 18 countries, with 26% occupying C-suite or board-level positions, and 30% coming from organizations with annual revenues exceeding $1 billion. Additionally, several in-depth interviews were conducted with industry experts to explore how biopharma companies are prioritizing sustainability and to examine the progress that has already been made.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online